Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Dermatology

  Free Subscription


23.03.2026

13 Am J Dermatopathol
2 Am J Ophthalmol
1 Am J Pathol
1 Ann Intern Med
1 BMC Cancer
6 Br J Dermatol
3 Cancer
6 Cancer Lett
3 Cancer Res
1 Clin Dermatol
3 Clin Exp Dermatol
10 Cutis
3 Int J Cancer
7 Int J Dermatol
5 Intern Med
2 J Cutan Pathol
2 J Dermatol
10 J Invest Dermatol
8 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. TRICHY NS, Braat J, Holic LJ, Olivares S, et al
    Malignant Transformation of Cellular Blue Nevus in a Lymph Node: A Case Report.
    Am J Dermatopathol. 2026;48:308-311.
    PubMed         Abstract available

  2. REIFELTSHAMMER C, Rongioletti F
    Livedo Reticularis With Perineural and Intraneural Mucin Deposition in a Child With AT-III Deficiency: A Case Suggestive of Neuropathia Mucinosa Cutanea?
    Am J Dermatopathol. 2026;48:305-307.
    PubMed         Abstract available

  3. TARANNUM R, Parker M, Grider DJ
    Nonconventional MYC-Positive Primary Cutaneous Angiosarcoma: Novel or Untested.
    Am J Dermatopathol. 2026;48:301-304.
    PubMed         Abstract available

  4. SWAMINATHAN S, Mizes A, Varghese S, Mercurio MG, et al
    Recurrent Papillary Apocrine Carcinoma of the Vulva.
    Am J Dermatopathol. 2026;48:294-300.
    PubMed         Abstract available

  5. LONG V, Joel LHL
    Checkerboard Hyperkeratosis With Apoptotic Keratinocytes as Features of Mechanic's Hands and Review of the Literature.
    Am J Dermatopathol. 2026;48:278-282.
    PubMed         Abstract available

  6. SHI J, Kalomeris T, Newman LA, Magro CM, et al
    Diffuse Dermal Angiomatosis of the Breast Presenting as Diffuse Erythema Mimicking Inflammatory Breast Carcinoma in a Healthy Pregnant Patient.
    Am J Dermatopathol. 2026;48:283-288.
    PubMed         Abstract available

  7. MARTINS KH, Silveira HA, Lara-Carrillo E, Lara-Fonseca MF, et al
    Pediatric Lymphomatoid Papulosis "Type E" Exclusively Involving the Oral Mucosa: Case Report and Review of the Literature.
    Am J Dermatopathol. 2026;48:267-270.
    PubMed         Abstract available

  8. PHILLIPOW N, Hong B, Vanderbeck K
    Biphasic Synovial Sarcoma With Neuroendocrine Differentiation: A Case Report.
    Am J Dermatopathol. 2026;48:289-293.
    PubMed         Abstract available

  9. SHORE KT, Mochel MC, Karpinski P, Sepehr A, et al
    Clinicopathologic and Molecular Analyses of 2 Basomelanocytic Tumors and Literature Review.
    Am J Dermatopathol. 2026;48:318-326.
    PubMed         Abstract available

  10. AREAN C, Revilla D, Minano R, Erana I, et al
    Subungual Reactive Eccrine Syringofibroadenoma: A Case Report.
    Am J Dermatopathol. 2026;48:316-317.
    PubMed         Abstract available

  11. PERRIN C, Dadone-Montaudie B, Petit F
    A New Nail Genodermatosis: Familial Onychocytic Hamartoma Presenting as Polydactylous Longitudinal Leukonychia. Implications in the Early Detection of BAP1 Tumor Predisposition Syndrome.
    Am J Dermatopathol. 2026;48:271-277.
    PubMed         Abstract available

  12. MAKHIJA M, Robinson J, Van Vliet C, Wood BA, et al
    Multiple Pruritic Papules and Nodules in a 50-Year-Old Woman: Challenge.
    Am J Dermatopathol. 2026 Mar 20. doi: 10.1097/DAD.0000000000003260.
    PubMed        

  13. GHALI H, Al-Bzour AN, Boby A, Aflatooni S, et al
    Associations Between Pigmentation and the Clinicopathologic and Immune Landscape of Melanoma.
    Am J Dermatopathol. 2026 Mar 20. doi: 10.1097/DAD.0000000000003223.
    PubMed         Abstract available


    Am J Ophthalmol

  14. ESEN F, Kokoglu A, Cetin C, Turkyilmaz O, et al
    Adalimumab-induced changes in NK cells phenotype, receptors and functions after clinical remission of Behcet's uveitis.
    Am J Ophthalmol. 2026 Jan 19:S0002-9394(26)00013.
    PubMed         Abstract available

  15. LISHINSKY-FISCHER N, Gharra S, Nitzan I, Chowers I, et al
    Reduced Risk of Non-Neovascular AMD in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Propensity-Matched Cohort Study.
    Am J Ophthalmol. 2026;284:153-160.
    PubMed         Abstract available


    Am J Pathol

  16. SINGH H, Taliyan R
    Epigenetic and Transcriptional Regulatory Networks Underlying Psoriasis Pathogenesis.
    Am J Pathol. 2026 Mar 17:S0002-9440(26)00066.
    PubMed         Abstract available


    Ann Intern Med

  17. KRISTENSEN FPB, Christensen DH, Callaghan BC, Nielsen JS, et al
    Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists on Diabetic Foot Disease : An Emulated Target Trial.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-01262.
    PubMed         Abstract available


    BMC Cancer

  18. WU M, Larkin J, Furness A, Stavropoulou C, et al
    The cost-effectiveness of tumour-infiltrating lymphocyte cell therapy for advanced melanoma: a systematic review.
    BMC Cancer. 2026 Mar 20. doi: 10.1186/s12885-026-15888.
    PubMed        


    Br J Dermatol

  19. LYNGSTRAND JE, Rossell EL, Bonnelykke-Behrndtz ML, Laurberg T, et al
    The impact of type 2 diabetes on sex- and stage-specific melanoma recurrence and mortality: A Danish cohort study, 2004 to 2024.
    Br J Dermatol. 2026 Mar 15:ljag097. doi: 10.1093.
    PubMed         Abstract available

  20. PHAN DB, Laws P, Smith CH, Griffiths CEM, et al
    Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Br J Dermatol. 2026 Mar 16:ljag098. doi: 10.1093.
    PubMed         Abstract available

  21. DAND N, Rayinda T, Silz E, Thomas LF, et al
    Genome-wide meta-analysis in lichen sclerosus identifies 14 genomic risk loci.
    Br J Dermatol. 2026 Mar 19:ljag088. doi: 10.1093.
    PubMed         Abstract available

  22. HARTLEY S, Judson-Torres RL
    How benign tumors grow: insights from melanocytic naevi.
    Br J Dermatol. 2026 Mar 20:ljag108. doi: 10.1093.
    PubMed        

  23. REFSUM E, Furu K, Cesta CE, Norgaard M, et al
    Topical retinoid use in women of reproductive age and risk of major congenital malformations in exposed pregnancies - a Nordic cohort study.
    Br J Dermatol. 2025 Dec 9:ljaf500. doi: 10.1093.
    PubMed         Abstract available

  24. BASKURT D, Altiner S, Atci T, Akay BN, et al
    Genotype-phenotype associations in a robust cohort of 69 patients with xeroderma pigmentosum across Turkiye: a multicentre study.
    Br J Dermatol. 2026;194:758-767.
    PubMed         Abstract available


    Cancer

  25. DESSINIOTI C, Stratigos A
    Neoadjuvant systemic immunotherapy for skin cancers.
    Cancer. 2026;132:e70354.
    PubMed         Abstract available

  26. FIELDS BC, Traweek RS, Jiang K, Witt RG, et al
    High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerability.
    Cancer. 2026;132:e70335.
    PubMed         Abstract available


  27. Correction to "Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele".
    Cancer. 2026;132:e70350.
    PubMed        


    Cancer Lett

  28. YUAN Q, Zhang H, Zhang N, Qian Y, et al
    BPHL promotes TNBC stemness by resolving R-loops via POLR2A lactylation inhibition and BARD1-mediated ubiquitination.
    Cancer Lett. 2026;645:218388.
    PubMed         Abstract available

  29. YANG C, Liu J, Kang X, Wang Z, et al
    PANX1-mediated NLRP3 inflammasome activation promotes an adaptive doxorubicin resistance through IL-1beta signaling in breast cancer.
    Cancer Lett. 2026;645:218387.
    PubMed         Abstract available

  30. WU CS, Chen HF, Huynh KT, Huang WC, et al
    Targeting PCK1 to overcome CDK4/6 inhibitor resistance for breast cancer therapy.
    Cancer Lett. 2026 Feb 24:218349. doi: 10.1016/j.canlet.2026.218349.
    PubMed         Abstract available

  31. VERMA S, Singh V, Lang JE, Gupta S, et al
    Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics.
    Cancer Lett. 2026;645:218350.
    PubMed         Abstract available

  32. XUE X, Ji D, Xue L, Tan Y, et al
    Spatially Resolved Transcriptomics Identifies Tumor-Stroma-Immune Networks and Therapeutic Targets in Endocrine-Resistant Advanced Breast Cancer Treated with Everolimus+Letrozole: Insights from the MIRACLE Trial.
    Cancer Lett. 2026 Feb 18:218327. doi: 10.1016/j.canlet.2026.218327.
    PubMed         Abstract available

  33. RUMNIEKS F, Vainshelbaum NM, Salmina K, Lazovska M, et al
    Resistance of BRAF(V600E)-mutant melanoma to Vemurafenib: a senescence-induced swing from differentiation to blastulation followed by proliferation.
    Cancer Lett. 2026 Mar 12:218430. doi: 10.1016/j.canlet.2026.218430.
    PubMed         Abstract available


    Cancer Res

  34. HU J, Zhang B, Chen J, Huang G, et al
    Cortactin Suppresses mTOR-Dependent Senescence in Circulating Tumor Cells.
    Cancer Res. 2026;86:1351-1371.
    PubMed         Abstract available

  35. PERURENA N, Watanabe M, Schade AE, Brown W, et al
    EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Pro-apoptotic Regulators.
    Cancer Res. 2026 Jan 5. doi: 10.1158/0008-5472.CAN-24-3113.
    PubMed         Abstract available

  36. XING Y, Tan Y, Hu B, Zhang H, et al
    PAK5-Mediated Suppression of beta-Hydroxybutyrate Production Promotes Breast Cancer Metastasis and Can Be Overcome with Ketogenic Diet.
    Cancer Res. 2026;86:1435-1450.
    PubMed         Abstract available


    Clin Dermatol

  37. YIGIT IK, Tursen U, Tursen B, Solak B, et al
    Aesthetic Interventions in Patients with Allergic Skin Diseases: Risk Assessment and Evidence-Based Preventive Risk Management.
    Clin Dermatol. 2026 Mar 13:S0738-081X(26)00060.
    PubMed         Abstract available


    Clin Exp Dermatol

  38. MORGAN H, Greenish H, Porter E, White C, et al
    Low Cost Community Lesion Imaging Clinics for Suspected Skin Cancer are Safe and Effective: A Retrospective Observational Cohort study.
    Clin Exp Dermatol. 2026 Mar 19:llag139. doi: 10.1093.
    PubMed         Abstract available

  39. MUSHTAQ S, Dogra D, Dogra N, Faizi N, et al
    Safety and efficacy of intralesional Amphotericin B in the treatment of Old World Cutaneous Leishmaniasis: A non-randomized open-label prospective study.
    Clin Exp Dermatol. 2026 Mar 18:llag136. doi: 10.1093.
    PubMed         Abstract available

  40. HOLDER E, Wagner C, Gregorowicz G, Merklen C, et al
    Mucocutaneous leishmaniasis misdiagnosed as cutaneous sarcoidosis for 4 years.
    Clin Exp Dermatol. 2026 Mar 14:llag131. doi: 10.1093.
    PubMed        


    Cutis

  41. WEISSON J, Wu S
    Development of Primary Cutaneous Anaplastic Large Cell Lymphoma Following Treatment With Upadacitinib for Atopic Dermatitis.
    Cutis. 2026;117:E47-E49.
    PubMed        

  42. HUANG CA, Chowdhury S, Waters-Hollingsworth C, Gamboa GM, et al
    Mobile Tender Papule on the Scalp.
    Cutis. 2026;117:11-15.
    PubMed        

  43. GUPTA R, Souchik A, Modi M, Mafee M, et al
    Primary Cutaneous Marginal Zone B-Cell Lymphoma Discovered During Mohs Surgery for Basal Cell Carcinoma.
    Cutis. 2026;117:E42-E44.
    PubMed        

  44. O'DONNELL A, Davey H, Markowitz O
    Dark-Brown Macule on the Periumbilical Skin.
    Cutis. 2026;117:29-32.
    PubMed        

  45. YILDIRIM MA, Korkmaz S, Celik HHA, Buyukbayram HI, et al
    Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis.
    Cutis. 2026;117:22-25.
    PubMed         Abstract available

  46. DEVINE M, Cho S, Norton SA
    Military Grooming Policy Changes Affecting Service Members With Pseudofolliculitis Barbae.
    Cutis. 2026;117:6-9.
    PubMed         Abstract available

  47. RENSTED AL, Hall A, Giancola J, Patel N, et al
    Intralesional Methotrexate: A Cost-Effective, High-Efficacy Alternative to Surgery for Cutaneous Squamous Cell Carcinoma.
    Cutis. 2026;117:E29-E32.
    PubMed         Abstract available

  48. SEBASTIAO E, Patton EI, Wong EB
    Interactive Approach to Teaching Mohs Micrographic Surgery to Dermatology Residents.
    Cutis. 2026;117:27-31.
    PubMed         Abstract available

  49. BRAZEN B, Griffith V, Akhtar A
    Photodermatoses: Exploring Clinical Presentations, Causative Factors, Differential Diagnoses, and Treatment Strategies.
    Cutis. 2026;117:E35-E38.
    PubMed         Abstract available

  50. BAGEL J, Hetzel A, Reed A, Nelson E, et al
    Safety and Effectiveness of Nonsteroidal Tapinarof Cream 1% Added to Ongoing Biologic Therapy for Treatment of Moderate to Severe Plaque Psoriasis.
    Cutis. 2026;117:16-25.
    PubMed         Abstract available


    Int J Cancer

  51. GROENEWEG R, van Ravesteyn NT, Kregting LM, Ursin G, et al
    Quality-adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen Norway.
    Int J Cancer. 2026;158:2537-2548.
    PubMed         Abstract available

  52. PINO-ROSON C, Avila-Arroyo S, Parra-Blazquez D, Soto Zabalgogeazcoa MJ, et al
    Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain.
    Int J Cancer. 2025 Dec 5. doi: 10.1002/ijc.70278.
    PubMed         Abstract available

  53. GUTZMER R, Weichenthal M, Eigentler T, Mohr P, et al
    Real-world effectiveness and safety with nivolumab plus ipilimumab or nivolumab alone in patients with or without melanoma brain metastasis: Results from the German noninterventional NICO study.
    Int J Cancer. 2026 Mar 15. doi: 10.1002/ijc.70440.
    PubMed         Abstract available


    Int J Dermatol

  54. MART HME, Aydemir AT, Pietkiewicz P, Akay BN, et al
    Acral Melanocytic Lesions Under Conventional, Sub-Ultraviolet Reflectance, and Ultraviolet-Induced Fluorescence Dermoscopy: A Comparative Analysis.
    Int J Dermatol. 2026 Mar 16. doi: 10.1111/ijd.70384.
    PubMed         Abstract available

  55. ALTAYF A, Lateiresh M, Marwan L, Alfeetouri MY, et al
    Efficacy and Safety of Oral Icotrokinra in Moderate-to-Severe Plaque Psoriasis: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
    Int J Dermatol. 2026 Mar 17. doi: 10.1111/ijd.70380.
    PubMed         Abstract available

  56. MA KS, Sol S, Boncimino F, Tsai SY, et al
    Effect of Diuretics on Cutaneous Squamous Cell Carcinoma: Clinical and Translational Evidence.
    Int J Dermatol. 2026 Mar 18. doi: 10.1111/ijd.70349.
    PubMed        

  57. HALIOUA B, Tan J, Gu C, Luger T, et al
    Retrospective Assessment of Social Rejection Related to Atopic Dermatitis During Childhood and Adolescence: The Scars of Life-Eczema Study.
    Int J Dermatol. 2026 Mar 19. doi: 10.1111/ijd.70375.
    PubMed        

  58. VALTELLINI L, Murgia G, Passoni E, Marzano AV, et al
    Myopericytoma as a Blue Cutaneous Lesion: A New Dermoscopic Presentation.
    Int J Dermatol. 2026 Mar 19. doi: 10.1111/ijd.70397.
    PubMed        

  59. GARATE D, Thang CJ, Lai J, Sanchez-Feliciano A, et al
    Bidirectional Association Between Periorificial Dermatitis and Type 2 Inflammatory Conditions: A Retrospective Cohort Study.
    Int J Dermatol. 2026 Mar 19. doi: 10.1111/ijd.70395.
    PubMed        

  60. PRABHA N, Bhatnagar A, P AS, Aruna P, et al
    Disseminated Cutaneous Rhinosporidiosis With Systemic Dissemination: A Case Report.
    Int J Dermatol. 2026 Mar 19. doi: 10.1111/ijd.70400.
    PubMed        


    Intern Med

  61. TOMIKI M, Matoba K, Sekiguchi K, Jinnai S, et al
    A Case of Fulminant Type 1 Diabetes Induced by Immune Checkpoint Inhibitors in a Patient with Autoimmune Predisposition.
    Intern Med. 2025 Aug 28. doi: 10.2169/internalmedicine.5970.
    PubMed         Abstract available

  62. MIGITA K, Matsumoto H, Yamasaki K, Mori F, et al
    A Patient with Pustulotic Arthro-osteitis with Isolated Spinal Lesions Successfully Treated with Risankizumab.
    Intern Med. 2026;65:895-899.
    PubMed         Abstract available

  63. KAWAKAMI E, Kamada Y, Fukui S, Jubashi T, et al
    Detection of Irpex lacteus in the Lung in a Case with Microscopic Polyangiitis-mimicking Manifestations Positive for Myeloperoxidase-antineutrophil Cytoplasmic Antibody.
    Intern Med. 2026;65:900-904.
    PubMed         Abstract available

  64. AOYAMA T, Mouri Y, Kaneko M, Nagata S, et al
    Successful Hemostasis for a Shock-inducing Hemorrhage from Anorectal Melanoma.
    Intern Med. 2026 Mar 17. doi: 10.2169/internalmedicine.7095.
    PubMed        

  65. SAKURAI T, Furui Ebisawa K, Koyama T, Ohji G, et al
    Salmonella Osteomyelitis with Cutaneous Fistula in an Immunocompetent Adult Presenting as a Tumor-Like Bone Lesion: A case report.
    Intern Med. 2026 Mar 17. doi: 10.2169/internalmedicine.6800.
    PubMed         Abstract available


    J Cutan Pathol

  66. DETTRICK A, Mohammed H, Hardman T, Buddle N, et al
    Desmoplastic Cutaneous Squamous Cell Carcinoma Is an Aggressive and Potentially Fatal Skin Cancer: A Systematic Review.
    J Cutan Pathol. 2026 Mar 15. doi: 10.1111/cup.70079.
    PubMed         Abstract available

  67. ALTINOZ GUNEY C, Koc HA, Cinar E
    How Perfectly Do Biopsy Request Forms and Pathology Reports Adhere to Guidelines in Basal Cell Carcinoma? A Retrospective Analysis of 851 Cases.
    J Cutan Pathol. 2026 Mar 17. doi: 10.1111/cup.70094.
    PubMed         Abstract available


    J Dermatol

  68. UCHIYAMA A, Yokoyama Y, Sekiguchi A, Shibusawa Y, et al
    A Familial Case of CYLD Cutaneous Syndrome With a Novel Nonsense Mutation in Japanese.
    J Dermatol. 2026 Mar 18. doi: 10.1111/1346-8138.70224.
    PubMed        

  69. MORI Y, Yamamoto A, Watanabe O, Enomoto Y, et al
    Successful Discontinuation of Systemic Corticosteroids With Secukinumab in a Pediatric Case of Generalized Pustular Psoriasis Harboring an IL36RN Mutation.
    J Dermatol. 2026 Mar 17. doi: 10.1111/1346-8138.70199.
    PubMed        


    J Invest Dermatol

  70. OLIVARES-GUERRERO M, Gonzalez-Quesada A, Sahuquillo-Torralba A, Rivera-Diaz R, et al
    Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules. BIOBADADERM Registry.
    J Invest Dermatol. 2026 Mar 11:S0022-202X(26)00753.
    PubMed         Abstract available

  71. PRINZ JC
    The HLA-C *06:02-presented skin immunopeptidome: A valuable resource for unravelling the autoimmune pathogenesis of psoriasis.
    J Invest Dermatol. 2026 Mar 18:S0022-202X(26)00063.
    PubMed        

  72. CHEN YH, Liau JY, Tsai JF, Liao YH, et al
    Spatial Lipidomics-based Melanoma Diagnostics by Integration of Mass Spectrometry Imaging and Machine Learning.
    J Invest Dermatol. 2026 Mar 17:S0022-202X(26)00963.
    PubMed         Abstract available

  73. MARSCHALL J, Schierhofer LIA, Santos AMS, Hinterseher J, et al
    Deep Analysis of Desmoglein-3-Reactive CD4(+) T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature.
    J Invest Dermatol. 2026;146:973-985.
    PubMed         Abstract available

  74. ASENSIO A, Sanz-Flores M, Liakath-Ali K, Romo-Gallo A, et al
    The G-Protein-Coupled Receptor Kinase 2 Orchestrates Hair Follicle Homeostasis.
    J Invest Dermatol. 2026;146:930-953.
    PubMed         Abstract available

  75. BOUDRA R, Patenall BL, King S, Carter KA, et al
    PRMT1 Inhibition Targets BNC1-Dependent Proliferation in Squamous Cell Carcinoma.
    J Invest Dermatol. 2026;146:1011-1027.
    PubMed         Abstract available

  76. VAN DEN HEUVEL A, Wondergem AP, Kim M, Breet I, et al
    A Splicing Variant in XPA Results in Delayed Onset of Clinical Features of Xeroderma Pigmentosum.
    J Invest Dermatol. 2026;146:1102-1114.
    PubMed         Abstract available

  77. HUANG J, Hu Y, Zhang Y, Jiang L, et al
    Integrating Multiomic Mendelian Randomization, Microarray, Single-Cell RNA Sequencing, and Spatial RNA Sequencing to Identify Potential Therapeutic Targets for Vitiligo.
    J Invest Dermatol. 2026;146:998-1010.
    PubMed         Abstract available

  78. PEREIRA MP, Butze M, Vera Ayala C, Kolkhir P, et al
    The Role of Mast Cells in the Pathophysiology of Chronic Prurigo.
    J Invest Dermatol. 2026;146:921-929.
    PubMed         Abstract available

  79. RUJITHARANAWONG C, Werth VP, Payne AS
    Boom or Bust: Clinical Trials in Pemphigus and Other B-Cell-Mediated Autoimmune Diseases.
    J Invest Dermatol. 2026;146:914-920.
    PubMed         Abstract available


    PLoS One

  80. ALIPOUR S, Jafari K, Saberi A, Motamedi M, et al
    What is the significance of a new breast mass in women aged 40 or above? A cross-sectional study.
    PLoS One. 2026;21:e0341732.
    PubMed         Abstract available

  81. WANG X, Xie C, Deng Y, Ren X, et al
    The association between psoriasis and nonalcoholic fatty liver disease: Mediation analysis involving inflammatory biomarkers among U.S. adults.
    PLoS One. 2026;21:e0344681.
    PubMed         Abstract available

  82. RAFI MSH, Millat MS, Barek MA, Dewan SMR, et al
    Association of NUDT17 rs9286836 and rs2004659 variants with breast cancer risk in Bangladeshi Women.
    PLoS One. 2026;21:e0344584.
    PubMed         Abstract available

  83. SIAM MBH, Khan MR, Elahe MF, Arman MS, et al
    Effects of similarity networks in graph-based multi-omics classification.
    PLoS One. 2026;21:e0344754.
    PubMed         Abstract available

  84. WANG J, Zhang T, Li P
    SegMan-based dual-prior network with boundary-augmented hybrid attention for robust skin lesion segmentation.
    PLoS One. 2026;21:e0344622.
    PubMed         Abstract available

  85. E AHMED NO, Mwalili S, Elbashir MK
    A lightweight deep learning framework for reliable microscopy-based diagnosis of cutaneous leishmaniasis.
    PLoS One. 2026;21:e0344561.
    PubMed         Abstract available

  86. ONAMBELE-PEARSON G, Ives B, Khosla I, Witkam R, et al
    Study protocol for a feasibility randomised controlled trial of MOVE SMART-An intervention to increase physical activity, reduce sedentary behaviour and improve health outcomes in patients with psoriasis.
    PLoS One. 2026;21:e0343922.
    PubMed         Abstract available

  87. ZHANG Y, Li W, Wang W, Wu K, et al
    A new perspective on population genetics: Deciphering the relationship between genetic variants and disease prevalence in Psoriasis.
    PLoS One. 2026;21:e0344204.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  88. FASSL A, Palacios Espinoza M, Butter D, Kolodziejczyk A, et al
    Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.
    Proc Natl Acad Sci U S A. 2026;123:e2522872123.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum